Ezetimibe and Simvastatin (Actavis Pharma, Inc.)
Welcome to the PulseAid listing for the Ezetimibe and Simvastatin drug offered from Actavis Pharma, Inc.. This Decreased Cholesterol Absorption [PE],Dietary Cholesterol Absorption Inhibitor [EPC],HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Actavis Pharma, Inc. |
| NON-PROPRIETARY NAME: | Ezetimibe and Simvastatin |
| SUBSTANCE NAME: | EZETIMIBE; SIMVASTATIN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Decreased Cholesterol Absorption [PE],Dietary Cholesterol Absorption Inhibitor [EPC],HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-04-26 |
| END MARKETING DATE: | 0000-00-00 |
Ezetimibe and Simvastatin HUMAN PRESCRIPTION DRUG Details:
| Item Description | Ezetimibe and Simvastatin from Actavis Pharma, Inc. |
| LABELER NAME: | Actavis Pharma, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 10; 10(mg/1; mg/1) |
| START MARKETING DATE: | 2017-04-26 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 45963-565_40e5d87c-92f4-4ca9-b95c-85290d90bdc6 |
| PRODUCT NDC: | 45963-565 |
| APPLICATION NUMBER: | ANDA202968 |
Other EZETIMIBE; SIMVASTATIN Pharmaceutical Manufacturers / Labelers:
